ARCHIVES

Taking on question of cost and outcomes, CMS turns to expert in cancer care quality.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

Indoor Tanning Industry Funded Author Of NEJM Review On Vitamin D Deficiency.

April 18, 2008

PRI, Fending Off More Giants, Reportedly wins New operations. Support contract at Frederick

July 10, 1987

Anna Barker Named Deputy Director for Strategic Scientific Initiatives

December 6, 2002

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

HEW Says Patent Delays Temporary

August 25, 1978